Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
LOC101927144 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
UBE2L3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
MIF-AS1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors
CIDEB - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
TRAPPC2L - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
DPY30 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
USB1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CHRM3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
AP2M1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ATP5G2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Profile neighbors
UPK3BL - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SF3B1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
NDUFA13 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
RPL29 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
MALSU1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CCNI - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SEC61A1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SLIT2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
MCF2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on